Identification of Gut Microbiota Profile Associated with Colorectal Cancer in Saudi Population.
Areej A AlhhazmiYahya Ahmad AlmutawifWalaa Abdullah MumenaShaima M AlhazmiTurki S AbujamelRuba M AlhusayniRaghad AloufiRazan R Al-HejailiRahaf AlhujailyLama M AlrehailiRuya A AlsaedyRahaf H KhojaWassal AhmedMohamed F AbdelmohsenWaleed Mohammed-SaeidPublished in: Cancers (2023)
Colorectal cancer (CRC) is a significant global health concern. Microbial dysbiosis and associated metabolites have been associated with CRC occurrence and progression. This study aims to analyze the gut microbiota composition and the enriched metabolic pathways in patients with late-stage CRC. In this study, a cohort of 25 CRC patients diagnosed at late stage III and IV and 25 healthy participants were enrolled. The fecal bacterial composition was investigated using V3-V4 ribosomal RNA gene sequencing, followed by clustering and linear discriminant analysis (LDA) effect size (LEfSe) analyses. A cluster of ortholog genes' (COG) functional annotations and the Kyoto Encyclopedia of Genes and Genomes (KEGG) were employed to identify enrichment pathways between the two groups. The findings showed that the fecal microbiota between the two groups varied significantly in alpha and beta diversities. CRC patients' fecal samples had significantly enriched populations of Streptococcus salivarius , S. parasanguins , S. anginosus , Lactobacillus mucosae , L. gasseri , Peptostreptococcus , Eubacterium , Aerococcus , Family XIII_AD3001 Group, Erysipelatoclostridium , Escherichia-Shigella , Klebsiella , Enterobacter , Alistipes , Ralstonia , and Pseudomonas (Q < 0.05). The enriched pathways identified in the CRC group were amino acid transport, signaling and metabolism, membrane biogenesis, DNA replication and mismatch repair system, and protease activity (Q < 0.05). These results suggested that the imbalance between intestinal bacteria and the elevated level of the predicated functions and pathways may contribute to the development of advanced CRC tumors. Further research is warranted to elucidate the exact role of the gut microbiome in CRC and its potential implications for use in diagnostic, prevention, and treatment strategies.
Keyphrases
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- global health
- genome wide
- peritoneal dialysis
- prognostic factors
- amino acid
- gene expression
- risk assessment
- mass spectrometry
- public health
- bioinformatics analysis
- staphylococcus aureus
- high resolution
- microbial community
- escherichia coli
- patient reported outcomes
- density functional theory
- molecular dynamics
- cystic fibrosis